Brazilian researchers have identified a molecule in the venom of an Amazonian scorpion capable of destroying breast cancer cells. This is coming as a groundbreaking discovery that could reshape the future of cancer therapy.
The bioactive compound, dubbed BamazScplp1, was isolated from the venom of the Brotheas amazonicus scorpion and shown to induce necrosis in cancer cells, causing them to rupture and die. The findings were recently presented during FAPESP Week France, a major international science and research event.
Led by scientists from the Butantan Institute and the University of São Paulo, the study harnessed a cutting-edge technique known as heterologous expression. This involves inserting genes linked to venom production into yeast cells, effectively turning them into tiny biofactories that can mass-produce venom proteins for testing. The method avoids the ethical and practical challenges of extracting large quantities of venom directly from animals.
“The necrosis induced by BamazScplp1 differs from apoptosis, which is a more controlled cell death process. Here, the cancer cells break apart, which could offer an advantage in certain therapeutic scenarios,” explained study co-author Dr. Bianca Souza, a postdoctoral researcher at the Butantan Institute.
Although the results are preliminary and yet to enter clinical trials, researchers say the findings add to the growing body of evidence that nature—particularly the biodiversity-rich Amazon rainforest—remains a largely untapped reservoir of powerful biomedical compounds.
This isn’t the first time animal venom has shown promise in medical research. Components derived from snakes, frogs, and even wasps have been investigated for use in treating conditions ranging from blood pressure to Alzheimer’s. However, the new scorpion-based molecule stands out for its specificity in targeting breast cancer cells, a disease that affects millions globally.
The discovery also underscores the urgency of preserving ecosystems like the Amazon, which may harbour the next medical breakthrough.
“The Amazon holds many secrets. This is just one example of why its conservation is not only a climate imperative but a public health priority,” said Dr. Eduardo Maffud Cilli, a chemistry professor involved in the research.
The team now aims to further analyze the mechanism behind BamazScplp1’s cancer-fighting properties and explore potential applications for other tumour types.
As the search for new cancer treatments intensifies worldwide, the tiny Amazonian scorpion may prove that big breakthroughs sometimes come in the smallest—and deadliest—packages.
Source: Agência FAPESP
